SAT-543 The use of non-invasive tests to detect and direct management of cirrhosis does not reduce the incidence or delay the onset of first severe decompensation events or improve survival: first report of the ELUCIDATE trial

Rosenberg, W., Tanwar, S., Ransom, M. et al. (8 more authors) (2026) SAT-543 The use of non-invasive tests to detect and direct management of cirrhosis does not reduce the incidence or delay the onset of first severe decompensation events or improve survival: first report of the ELUCIDATE trial. In: Journal of Hepatology. EASL Congress 2026, 27-30 May 2026, Barcelona, Spain. Vol. 84 (Supplement 1). Elsevier. Article no: SAT-543, S256. ISSN: 0748-7983. EISSN: 1532-2157.

Metadata

Item Type:	Conference abstract
Authors/Creators:	Rosenberg, W. Tanwar, S. Ransom, M. Muli, A. Stocken, D. https://orcid.org/0000-0001-8031-1738 Richardson, P. Jones, R. Moreea, S. Ch’ng, C.L. Neuberger, J. Selby, P.
Dates:	Published (online): 27 May 2026 Published: 27 May 2026
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:	Funder Grant number NHS Health Technology Assessment NONE GIVEN
Date Deposited:	15 Jun 2026 10:04
Last Modified:	15 Jun 2026 10:04
Published Version:	https://www.sciencedirect.com/science/article/pii/...
Status:	Published
Publisher:	Elsevier
Identification Number:	10.1016/s0168-8278(26)00879-2
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:241920

CORE (COnnecting REpositories)

SAT-543 The use of non-invasive tests to detect and direct management of cirrhosis does not reduce the incidence or delay the onset of first severe decompensation events or improve survival: first report of the ELUCIDATE trial

Metadata

Download not available

Export

Statistics